Historical lrcx News Stories
LRCX: China 50% Rule Shifts Revenue Mix, Upgrades
Lam Research (LRCX) faces a measurable revenue hit from China’s new 50% domestic-equipment requirement, while AI and memory spending, analyst target upgrades, dividends and onshoring efforts create offsetting tailwinds.
LRCX Soars on AI Demand; CEO Sells $27M Stock Up!!
Lam Research stock rallied to fresh highs after strong systems revenue driven by AI-foundry demand, coupled with analyst upgrades. CEO Tim Archer executed a pre-scheduled $27M sale, while Lam’s leadership in etch and deposition and growing foundry exposure underpin near-term momentum.
LRCX Drop After Intel Tests ACM Wet-Etch Tools Now
Lam Research shares fell after reports that Intel is evaluating lower-cost wet-etch tools from ACM Research, raising competitive and policy concerns even as semiconductor equipment demand remains strong. This article breaks down the near-term catalyst, Lam’s technological strengths, and what investors should watch next.
Lam Research Surges as AI Chip Demand Fuels Gains
Lam Research (LRCX) climbed to a new 52-week high as AI-driven wafer fabrication spending and heavy institutional buying offset regulatory export risks. Key drivers include UBS conference guidance on AI WFE elasticity, robust NAND spending forecasts, and sizable 13F accumulation by major funds.
Lam Research Nears 52-Week High on AI Demand Gains
Lam Research (LRCX) rallied into early December, trading near its 52-week high as AI-driven wafer fab spending lifts sentiment. Recent session-level volatility, muted volumes, and lingering export-control exposure to China create a mixed near-term outlook for the stock.
Lam Research: Foundry Surge & VECTOR TEOS 3D FY26!
Lam Research (LRCX) reported a sharp jump in Systems revenue driven by foundry demand, launched the VECTOR TEOS 3D deposition tool for advanced 3D packaging, and announced capital returns plus a strategic cross-licensing deal—moves that reinforce its role in AI/HPC-driven chip production.
LRCX Faces CHIPS Act Shift; Stock React Outlook Q4
Recent U.S. legislation and policy moves this week directly affect Lam Research (LRCX). A proposed CHIPS Act restriction on Chinese-made equipment, strong relative share gains, and a short-term pullback combine to create a policy-driven demand tailwind alongside near-term technical volatility.
LRCX Drop Morgan Stanley Cuts Rating; Insider Sell
Lam Research (LRCX) fell after Morgan Stanley downgraded the stock and lowered its price target, while a senior executive’s multi-million-dollar share sale and stalled Chinese consolidation added to investor caution. This article reviews the concrete events from the past week, explains why they matter for LRCX, and lists what investors should watch next.
Lam Research: $0.26 Dividend and MS Upgrade Boosts
Lam Research announced a $0.26 quarterly dividend and benefits from a Morgan Stanley upgrade amid a rebound in memory wafer fab equipment spending. Concrete developments this week reinforce LRCX's cash return strategy and improved demand visibility, while analysts note the company’s relatively smaller exposure to China export curbs versus peers.